A new analysis from the US Government Accountability Office shows that, in 2017, the Department of Veterans Affairs paid prescription drug prices that were on average 54% lower than what was paid by Medicare, which by law is not currently allowed to negotiate down the prices that drugmakers choose […]
Fierce JPM Week Partner Content Hub
This is a different approach to enabling our partners to share solutions and stories with you in a virtual environment. Here at Fierce JPM Week attendees can engage with digital assets in a way that is easy to navigate, learn from and share with peers and colleagues. This hub provides access to […]
New Book Release by RJG Arnold: Pharmacoeconomics: From Theory to Practice
An understanding of the basic principles of pharmacoeconomics is essential if stakeholders in the healthcare arena hope to meet the burgeoning challenges posed by shrinking budgets, healthcare rationing, medication shortages, and an aging global population. The 2nd edition of Pharmacoeconomics: From […]
New Data Show Retail Medicine Prices Fell in 2019
In 2019, retail prescription medicine prices declined by 0.4%, on average, according to National Health Expenditures (NHE) data from the Centers for Medicare & Medicaid Services (CMS) published recently in Health Affairs. While retail prescription medicine spending grew 5.7% that same year, this […]
Pandemic Propels Health Systems to Mull Acquisitions, Partnerships
Nearly a year after the first confirmed case of COVID-19 in the U.S., some of the nation's largest health systems made a case for the need to accelerate toward value-based arrangements and potentially acquiring or partnering with health plans to become an integrated system. Amid new records for […]
Gaps in Health Data are Barrier to Health Equity
COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / Pacific Islanders are up to 2.5 times higher as compared to whites. Similarly, the rate of COVID-19 related deaths among Black Americans and American Indian/Alaskan […]
Cerner Aspires to Build $1B Data Business in Pharma Market
Building on its acquisition of clinical research company Kantar Health, health IT giant Cerner is setting its sights on building a $1 billion data business for the healthcare and life sciences industries. Cerner announced plans in December to acquire the health division of Kantar Group, which […]
[Podcast] Creating an HEOR Function Within Medical Affairs
In this episode of the MAPS Elevate podcast series, we explore Health Economics and Outcomes Research (HEOR), looking at why a Medical Affairs organization needs an HEOR function and how to build this capability within Medical Affairs. This podcast is brought to you by AlphaGroup an independent […]
Implications of Price Transparency for Providers and Patients as New Rules Go into Effect
A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and market pricing. As of January 1, 2021, the United States Department of Health and Human Services requires that hospitals publish payer-negotiated rates for common […]
STaRT-RWE: Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies
In alignment with the International Council of Harmonization’s strategic goals, a public-private consortium has developed a structured template for planning and reporting on the implementation of real world evidence (RWE) studies of the safety and effectiveness of treatments. The template serves as […]
Disparities in the Wage‑and‑Salary Earnings of HEOR Professionals
Using self-reported survey data collected in 2017 from a subset of HE/OR/MA professionals in the HealthEconomics.com global subscriber list, researchers performed a study aiming to estimate the wage-and-salary earnings of a sample of health economics, outcomes research, and market access (HE/OR/MA) […]
2021 ARM – Call for Abstracts
Present your work at the premier forum for health services researchers, policy analysts, clinicians and community leaders using evidence and data to improve health and health care for all. The 2021 Annual Research Meeting is organized around 21 themes and five submission types. All individual […]
Specialty Generics Face Perverse Incentives In Medicare Part D
Whether specialty generics are cheaper to payers than their originator branded counterparts is partly a function of the level of rebates drugmakers are willing to offer to a pharmacy benefit manager (PBM) to secure preferred placement on the formulary. Originator firms can outmaneuver specialty […]
Guest Blog Posts for the Journal of HEOR Website
The Journal of Health Economics and Outcomes Research is currently in the process of soliciting guest blog posts for the JHEOR web site and wanted to invite you to participate in this opportunity. We're seeking submissions on a range of topics related to HEOR and, in particular, right now, posts […]
Race Rarely at Top of Patient’s Medical Record
Even though differences in health outcomes between Black and white people are well-established, a small survey finds that patients' race is not routinely mentioned atop their electronic medical record. The survey looked at data from 1,200 patients, and checked for race in the first line of the EMR […]
Drugmakers Raise Prices 3.3% in the New Year
This month pharmaceutical companies have increased list prices on hundreds of branded drugs -- mostly between 2-7% (with only a couple companies daring the optics of double-digit hikes). In aggregate, however, the rate of increase across a market basket of the most common branded therapies was lower […]
ICER Identifies Most Significant 2019 US Drug-Price Hikes
The Institute for Clinical and Economic Review (ICER) today published its latest report on Unsupported Price Increases (UPI) of prescription drugs in the United States. Among the top drugs with price increases in 2019 that had substantial effects on US spending, ICER determined that seven of 10 […]
EQRx Scales Disruptive Model of Important New Medicines
EQRx, a company committed to developing and delivering important new medicines at lower prices, today announced that it has raised $500 million in Series B financing. Since launching a year ago, EQRx has raised approximately $750 million to advance its mission of bringing new medicines to treat […]
[On-demand Webinar] Avalere 2021 Healthcare Industry Outlook
The accelerated changes and increased uncertainties in healthcare brought on by the COVID-19 pandemic will continue into 2021, and its impacts are likely to shape healthcare for years to come. While prevalent uncertainty is a given, the broad outline of a new era is already emerging. More than ever, […]
Fishawack Health Acquires The Hive Health Group
Fishawack Health (Fishawack) is a leading global commercialization partner for the modern life sciences era. The company’s three core operating units—Commercial, Consulting, and Medical Communications—can be leveraged individually but are designed for dynamic collaboration, with expert teams […]
Virtual ISPOR 2021 Abstracts Due & Reviewers Needed!
Virtual ISPOR 2021 offers you an opportunity to present your research virtually to the leading global conference for health economics and outcomes research. Submit today and contribute to the future of HEOR and the difference it is making in today’s global healthcare landscape. New This Year: […]
The 5 Numbers That Will Define Healthcare Value in 2021
Real world studies of COVID-19’s impact on health care utilization are arriving daily and their continued publication throughout the next year will be the defining characteristic of HEOR in 2021. One systematic review (in preprint) has already reported on 81 such studies. In these studies, which […]
Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets
Unlike private health insurance, Medicare Part D drug plans have no cap on patients’ 5% coinsurance costs once they hit $6,550 in drug spending this year (up from $6,350 in 2020), except for very low-income beneficiaries. President-elect Biden favors a cap, and Democrats and Republicans in Congress […]
Read Up On How Regulators Are Using RWE
RWE is playing a growing role in FDA approvals. According to an Aetion analysis, 49 percent of submissions for new drugs and biologics in 2019 included an RWE study. In 2020, that figure jumped to 75 percent. In Aetion’s growing library of FDA Decision Alerts, they share examples in which RWE was […]
The Bane of Prior Authorization
In a STAT op-ed, Brian Barnett, a psychiatrist at the Cleveland Clinic, discusses the burden of completing prior authorizations to ensure patients can retain access to medications. While prior authorizations can be used to ethically and efficiently steer patients toward lower-cost, clinically […]
Has COVID-19 Changed Prescription Drug Pricing Forever?
As the COVID-19 pandemic continues to disrupt our lives and health care system on a historic scale, it is worth considering whether it has also revolutionized drug development and pricing in a profound way. COVID-19 vaccines were produced in record time using a novel approach: Drug makers committed […]
ICER To Release Final Assessment of Selected High-impact Drugs
ICER will be reviewing changes in the evidence base for each of these drugs and assess whether or not new clinical data exists that could suggest that the drugs could be significantly more beneficial for patients than what was previously understood. ICER published the final draft of its first UPI […]
Enjoy AMCP Learn Programs Available to You
AMCP Learn provides numerous on-demand CPE programs that will help you with your goals. Enjoy programs like Navigating Changes in Clostridioides difficile Prevention and Treatment, Value-based Contracting, Fundamentals of Managed Care Pharmacy Certificate Programs, and more! […]
Volunteer with AMCP Foundation
Give the gift of time by volunteering. The AMCP Foundation has opportunities for you to donate your time. Volunteering is a great way to be hands-on as you help fulfill our mission of research and education. Become a volunteer today! AMCP Foundation P&T Competition Judges(Apply by Jan. 17, […]
The AMCP Podcast Powered by PopHealth Week Launches Next Week
AMCP is proud to partner with renowned health care experts Fred Goldstein and Gregg Masters from PopHealth Week to launch a podcast that fosters conversation about the biggest challenges facing managed care pharmacy and up-to-the minute hot topics. They are shining the spotlight on leading voices […]
